HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prop 65 listing

This article was originally published in The Rose Sheet

Executive Summary

California Office of Environmental Health Hazard Assessment extends public comment period for di-n-butyl phthalate, butyl benzyl phthalate, di-n-hexyl phthalate and di-isodecyl phthalate to May 24, agency says. OEHHA announced plans to list the substances under Proposition 65 as chemicals known to the state to cause reproductive toxicity on March 4 and initiated a 30-day comment period closing April 4 (1"The Rose Sheet" March 14, 2005, p. 7). Deadline was extended following a request from an interested party seeking more time to submit complete and relevant scientific information, OEHHA says...

You may also be interested in...



Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012950

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel